Glioma

Among menopausal women, hormone therapy use and duration were not associated with brain malignancy risk, although researchers cautioned that more research is needed, according to findings published in Menopause.

The addition of temozolomide to radiation therapy prolonged OS for patients with both co-deleted and non-co-deleted grade 2 gliomas, according to study results.

In this video, Tracy T. Batchelor, MD, head of the department of neurology at Brigham and Women's Hospital, discusses the targeted therapies available or in development that target specific mutations in gliomas.

Today is Glioblastoma Awareness Day.

The FDA announced several regulatory actions the past few weeks.

CHICAGO — Vorasidenib significantly improved PFS while delaying time to next intervention among certain patients with grade 2 isocitrate dehydrogenase 1- or 2-mutant glioma, according to data presented at ASCO Annual Meeting.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses novel and experimental treatments for brain cancer.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses current challenges and opportunities in glioma treatment.

In this video, Patrick Wen, MD, professor of neurology at Harvard Medical School and director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute, discusses how diagnostic techniques for brain cancer are evolving.